MysteryVibe creates doctor-recommended sexual health devices. The company combines research and engineering by onboarding leading doctors to design devices that address major sexual health issues such as erectile dysfunction, dryness and pain during intercourse. MysteryVibe has changed over 50,000 lives in 65 countries, witnessed $1 million worth of direct sales in 2020, and became the first sexual health startup to be featured on a BBC documentary. The company has received 20+ international awards including, the coveted Design Week Awards where its product, 'Crescendo', beat the Apple Watch. MysteryVibe has featured in media entities like Men's Health, Women's Health, The Daily Dot, and Forbes, to name a few. The company will use 25% of the investment to expand and scale its digital marketing campaign, 25% to launch two new products, 25% to expand its team, and 25% on building its inventory.
days to go:
Expired
investment:
£498,020
miiCARE is a MedTech specialising in AI applied to geriatrics (elderly care). Its key product miiCUBE offers cutting-edge home-based and customised healthcare, helping the elderly enjoy their independence while being comprehensively connected to their families, friends, and neighbours. The company aims to provide these benefits to one billion people by 2028, comprising older people, family members and carers. Till date, miiCARE has secured partnerships with the UK’s largest NHS trust, Ebbsfleet Garden City, O2, Bristol Careline and Microsoft, and won multiple social impacts and digital health awards during the last 12 months. Funds raised will be used mainly for fulfilling pre-orders and close interests for large contracts with corporates, marketing and logistics, product development, sales and salaries.
days to go:
Expired
investment:
£103,672
Medic Bleep is a secure and real-time communication solution that aims to help medical teams communicate and collaborate effectively, reduce costs, and improve patient outcomes. It argues that poor inter-team communication has led to an estimated 400,000 episodes of potential harm a year, in the National Health Service (NHS) alone. Medic Bleep aspires to change this. It points out that its services have saved an average of £2.5 million worth of potential harm expenses per NHS Trust. The company asserts that its services are now being used by 5,600+ staff across hospitals every month. Medic Bleep has partnered with the BT Group targeting 20% of NHS trusts by 2025. It has 5,600 monthly active users and has witnessed 18,000 app downloads on multiple platforms. The company will use the investment to develop Version 2 of its product, deliver on its BT contract and NHS X framework to increase sales, and explore other geographies.
days to go:
Expired
investment:
£455,375
Lumio is an intelligent and independent application that intends to help people grow their money on autopilot. Lumio argues that £176 billion of lazy money is depreciating in the UK while for Europe, that number stands at £10 trillion. Lumio aims to optimise this money for everyone so that everyone can gain access to financial security and decide their financial future. The company claims that over £90 million worth of user transactions has been analysed by its smart algorithm. It has more than 6000 users on iOS and Android, which is growing 20% monthly. Lumio was recognised as part of the 'Top 100 Fintech Disruptor' by BusinessCloud in 2020, ahead of Monzo and Seedrs. It has also featured in Forbes, Tech Nation and Sifted by FT. It will use the investment to grow 1 million customers' money by 2024 and accelerate financial independence and personal progress through its technology.
days to go:
Expired
investment:
£1,149,659
Lenderwize is the first lending platform for Telecom Operators, offering investment opportunities in a new Asset Class. Its typical clients are mid-sized operators with an annual revenue of 50-300 million USD. Lenderwize sells to large Tier1 Operators (Originators) and buys from smaller (Terminating) Operators. Thanks to Lenderwize's in-depth industry knowledge, they have identified 1350 wholesalers in need of $96 million, making the Cost of Acquisition of clients very low. Additionally, its lean Back Office, Credit Vetting and Loan Management gives Lenderwize a competitive edge over Market Invoice or Funding Circle. With the funds, the company will invest in technology development and integration, increasing sales, marketing activities, and recruitment to enhance its reach globally.
days to go:
Expired
investment:
£100,045
HyperionDev teaches people to code through online courses overseen by top code reviewers. It asserts that its core innovation was efficiently connecting top students to struggling ones having them review code on structured courses. This led to HyperionDev being financially backed by technology giants Facebook and Google in 2016/17 helping the company scale its computer-assisted code review process. HyperionDev has registered over 150,000 students and onboarded clients like Lambda School and Makers. The company reached profitability in 2020 earning £1 million in revenue and more than 250% user growth. It will use the investment to commercialise its model in the $300 billion tech education and assessments market and close the tech skills gap.
days to go:
Expired
investment:
£1,999,998
Honcho is the UK’s first reverse auction marketplace for financial services that is revolutionising the car insurance market. In a reverse auction, the company works by inviting insurance providers to bid against one another. For just £1 a bid, insurance providers can go head to head to give the customer their best price and helping the latter to avoid any hidden charges and commission. Honcho's first major £830,000 funding round closed in March 2018 with support from crowd investors plus Maven Capital Partners. The company has just launched its first partner integrations, bringing its services to consumers of two major employee benefits platforms plus a major affiliate network. Honcho was selected for the 'Tech Nation Fintech programme 2019.' Honcho will use the investment to diversify its investor base and bring itself to a platform with support for Insurtech businesses, launch offers in other sectors, evolve its role as Platform as a Service (PaaS), and enhance marketing initiatives.
days to go:
Expired
investment:
£1,433,325
Hexis is a fitness application that helps users become fitter scientifically, fuel smarter and feel on top of their game. The company argues that despite users becoming knowledgeable in fitness, courtesy of the internet, nutrition hasn’t become a core area of concern. Hexis asserts that its proprietary 'Carb Coding' tool amplifies the human body's response to exercise, enhancing performance, recovery and adaptation. Hexis stresses that its tool removes the guesswork from nutrition by predictively personalising a user's requirements as per their workouts and lifestyle. The company points out that its beta system was tested on 1,000 users. It aspires to dominate the personalised nutrition market that is set to grow to £11.7 billion by 2027 and counts athletes like Paul Dunne (Golf), Rohan Dennis (Cycling), and Lauren Delany (Rugby) amongst its star users. Hexis states it will use the investment to democratise nutrition and increase its user base across global markets.
days to go:
Expired
investment:
£398,234
Grid Duck (GD) is an intelligent energy control system. It argues that only 14% of commercial buildings have a Building Management System (BMS) that allows them to switch off appliances when they are not needed automatically. GD is trying to bring the remaining 86% of buildings under its network. It has launched a wireless cloud-based system for companies to manage their energy consumption. Companies can check their energy consumption on an easy-to-use dashboard. GD is also evolving its technology into a self-learning system that supports time-of-use tariffs, demand response and renewables balancing. The company won the 2020 Rushlight Energy Reduction Award, and is ISO27001 certified for cybersecurity with regards to 'Penetration Test'. With the investment received, the company will grow its revenues and invest in New Product Development (NPD).
days to go:
Expired
investment:
£339,771
Gendius is a company that aims to bring pharmaceuticals and health economics, through clinical research and evidence, to the mobile health market. Their latest innovation, Intellin, is an intelligent remote management diabetes platform, with over 140,000 downloads so far. The COVID-19 crisis has highlighted the need for remote home monitoring of patients, and the company feels that its product is a suitable contender in this domain. Intellin has a reliable connection to over 150 medical devices and apps, and also consists of a two-way communication setup with a healthcare professional via a secure dashboard. Gendius is registered as an approved vendor with AstraZeneca in Saudi Arabia and looks to establish deeper relations with the National Health Service (UK) to create a demand for its product. The company will use the investment to scale its business globally, drive commercialisation, offer an opportunity to its stakeholders, and target venture capital.
days to go:
Expired
investment:
£386,829
